Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Short-term effects of sibutramine (ReductilTM) on appetite and eating behaviour and the long-term therapeutic outcome

International Journal of Obesity volume 27, pages 693–700 (2003)Cite this article

Abstract

OBJECTIVE: To evaluate the short-term effects of sibutramine on appetite and eating behaviour and whether these effects are related to the long-term therapeutic outcome.

STUDY DESIGN: Short-term: randomised, double-blind, placebo-controlled, within-subject design. Long-term: prospective open clinical trial.

SUBJECTS: A total of 36 obese (nine men/27women) with a body mass index of 39.3±4.3 (mean±s.d.) (range 30.2?–?45.2)?kg/m2 and age 44.4±12.1?y.

PROCEDURE AND METHODS: First phase—short-term effects: At baseline, the subjects were treated for 14 days with 15?mg sibutramine/placebo (period 1) followed by a 2 weeks single-blind placebo washout period, the subjects received the alternative therapy for another 14 days (period 2). At baseline, and at day 14 in each treatment period the subjects arrived fasting to the laboratory for a standardised breakfast and an ad libitum standardised lunch using the VIKTOR set-up (a universal eating monitor) to evaluate the microstructure of the eating behaviour (ie amount of food consumed and eating rate). Visual Analogue Scales were applied before and after the meals as well as every hour between the meals to monitor the appetite. During this first phase, subjects were encouraged to keep their habitual eating habits. Second phase—long-term effects: All subjects received 10 months open treatment with 15?mg sibutramine and dietary advice in monthly group sessions with a dietitian. On the last day of this treatment period, the subjects returned to repeat the measurements of appetite and eating behaviour using the same test procedure as during the first phase of the study.

RESULTS: First phase: Sibutramine influenced appetite and eating behaviour that could be registered after only 14 days of treatment. The amount of food consumed at lunch on VIKTOR was reduced by 16% by sibutramine compared to placebo, 335±123?g vs 399±126?g (P<0.0001). Second phase: Responders and nonresponders were defined as those who ate less vs more food on VIKTOR when treated with sibutramine compared to the baseline food intake in the first phase of the study. The weight reduction was greater for responders 11.8±6.2 (mean±s.d.)?kg compared to nonresponders 6.8±2.7 (mean±s.d.)?kg (P<0.05).

CONCLUSION: Short-term effects of sibutramine on appetite and eating behaviour were identified such as a reduction in food intake and in ratings of subjective motivation to eat. Short-term sibutramine effects on eating behaviour are to some extent related to the long-term therapeutic outcome in obese subjects.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. WHO. Obesity, preventing and managing the global epidemic. World Health Organisation: Geneva; 1997.

  2. McNeely W, Goa KL . Sibutramine—a review of its contribution to the management of obesity. Drugs 1998; 56: 1093–1124.

    Article  CAS  Google Scholar 

  3. James WP, Astrup A, Finer N, Hilsted J, Kopelman P, Rössner S, Saris WHM, Van Gaal LF . Effect of sibutramine on weight maintenance after weight loss: a randomised trial. Lancet 2000; 356: 2119–2125.

    Article  CAS  Google Scholar 

  4. Lissner L, Barker DJP, Blundell JE, Dietz WH, Epstein LH, Jeffery RW, Remschmidt H, Rolls BJ, Rössner S, Saris WHM . Group report: what are the bio-behavioral determinants of body weight regulation? In: Bouchard C, Bray GA (eds.). Regulation of body weight: biological and behavioral mechanisms, John Wiley & Sons; Chichester, New York, Brisbane, Toronto, Singapore; 1996. pp 159–177.

    Google Scholar 

  5. Barkeling B, Rössner S, Björvell H . Effects of a high-protein meal (meat) and a high-carbohydrate meal (vegetarian) on satiety measured by automated computerized monitoring of subsequent food intake, motivation to eat and food preferences. Int J Obes Relat Metab Disord 1990; 14: 743–751.

    CAS  Google Scholar 

  6. Barkeling B, Rössner S, Sjöberg A . Methodological studies on single meal food intake characteristics in normal weight and obese men and women. Int J Obes Relat Metab Disord 1995; 19: 284–290.

    CAS  Google Scholar 

  7. Lindgren AC, Barkeling B, Hägg A, Ritzén M, Marcus C, Rössner S . Eating behaviour in Prader–Willi syndrome, normal weight and obese control groups. J Pediatr 2000; 137: 50–55.

    Article  CAS  Google Scholar 

  8. Meyer J-E, Pudel V . Experimental studies on food intake in obese and normal weight subjects. J Psychosom Res 1972; 16: 305–308.

    Article  CAS  Google Scholar 

  9. Blundell JE, Rogers PJ, Hill AJ . Evaluating the satiating power of foods: implications for acceptance and consumption. In: Solms J (ed). Chemical composition and sensory properties of food and their influence on nutrition. Academic Press; London; 1988. pp 205–219.

    Google Scholar 

  10. Nordic Nutrition Recommendations. Scand J Nutr 1996; 40: 161–165.

  11. Linné Y, Barkeling B, Rössner S, Rooth P . Vision and eating behavior. Obes Res 2002; 10: 92–95.

    Article  Google Scholar 

  12. Barkeling B, Granfelt Y, Björck I, Rössner S . Effects of carbohydrates in the form of pasta and bread on food intake and satiety in man. Nutr Res 1995; 15: 467–476.

    Article  Google Scholar 

  13. Hylander B, Barkeling B, Rössner S . Eating behaviour in continuous ambulatory peritoneal dialysis and hemodialysis patients. Am J Kidney Dis 1992; 6: 592–597.

    Article  Google Scholar 

  14. Hylander B, Barkeling B, Rössner S . Changes in patients' eating behavior: in the uremic state, on continuous ambulatory peritoneal dialysis treatment, and after transplantation. Am J Kidney Dis 1997; 29: 691–698.

    Article  CAS  Google Scholar 

  15. Näslund E, Barkeling B, King N, Gutniak M, Blundell J, Holst J, Rössner S, Hellström P . Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men. Int J Obes Relat Metab Disord 1999; 23: 304–311.

    Article  Google Scholar 

  16. Rössner S, Barkeling B, Asp A, Flaten H, Fuglerud P . Effects of weight loss on single meal eating behaviour in obese subjects. Int J Obes Relat Metab Disord 1996; 20: 287–289.

    PubMed  Google Scholar 

  17. Rössner S, Barkeling B, Erlanson-Albertsson C, Larsson P, Wåhlin-Boll E . Intravenous enterostatin does not affect single meal food intake in man. Appetite 1995; 24: 37–42.

    Article  Google Scholar 

  18. Rolls BJ, Shide DJ, Thorwart ML, Ulbrecht JS . Sibutramine reduces food intake in non-dieting women with obesity. Obes Res 1998; 6: 1–11.

    Article  CAS  Google Scholar 

  19. Andersson JW, Konz EC . Obesity and disease management: effect of weight loss on comorbid conditions. Obes Res 2001; 9: 326S–334S.

    Article  Google Scholar 

  20. McMahon FG, Fujioka K, Singh BN, Mendel CM, Rowe E, Rolston K, Johnson F, Mooradian AD . Efficacy and safety of sibutramine in obese White and African American patients with hypertension. Arch Intern Med 2000; 160: 2185–2191.

    Article  CAS  Google Scholar 

  21. Bray GA . Drug treatment of overweight. Contemporary diagnosis and management of obesity. Handbooks in Health Care Co.: Newtown, PN; 1998. pp 246–273.

    Google Scholar 

Download references

Acknowledgements

Our thanks are particularly to Birgitta Spetz and Karin Östling and also to Birgit Hännikäinen, Lena Mannström, Viveka Petre Larsson, Jonas Ramsten and Josefine Jonasson for always taking good care of the patients in the study. This study was supported by grants from Abbott Pharmaceutical (former Knoll Pharmaceutical).

Author information

Author notes

  1. P Rooth: Deceased.

Authors and Affiliations

  1. Obesity Unit, Institute of Internal Medicine, Huddinge University Hospital, Stockholm, Sweden

    B Barkeling, K Elfhag, P Rooth & S Rössner

Authors
  1. B Barkeling
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K Elfhag
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P Rooth
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S Rössner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to B Barkeling.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Barkeling, B., Elfhag, K., Rooth, P. et al. Short-term effects of sibutramine (ReductilTM) on appetite and eating behaviour and the long-term therapeutic outcome. Int J Obes 27, 693–700 (2003). https://doi.org/10.1038/sj.ijo.0802298

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijo.0802298

Keywords

This article is cited by

Search

Advanced search

Quick links